MarketPulse
S

$SENS

5 articles found
5 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Senseonics Raises $80M to Fund Eversense 365 Launch and Pipeline Expansion

Senseonics raises $80M through common stock and pre-funded warrant offering to fund Eversense 365 launch and pipeline development, closing May 4, 2026.
SENSpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

CGM Market Booming in Middle East and Africa: 168% Growth Projected by 2034

Middle East and Africa CGM market projected to reach USD 855.30 million by 2034 from USD 320.44 million in 2025, growing at 11.53% CAGR.
MDTABTDXCMSENShealthcare technologymarket forecast
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Senseonics Expands European Footprint With Eversense 365, Doubling CGM Sensor Lifespan

Senseonics launches Eversense 365 implantable glucose monitor in Europe with one-year lifespan. Q4 revenue surged 72% year-over-year to $14.3 million.
SENSEuropean expansionmedical device
BenzingaBenzinga··Equity Insider

AI and Remote Care Transform MedTech: A Shift to Scalable, Outpatient-First Healthcare

Healthcare pivots toward outpatient services as AI diagnostics and remote monitoring technologies gain traction. Multiple medtech firms advance innovative solutions addressing cost and accessibility.
LIVNCLOVMBOTSENSValue-Based CareAI diagnostics
GlobeNewswire Inc.GlobeNewswire Inc.··Senseonics Holdings, Inc.

Senseonics' Eversense 365 Proves Durable: Real-World Data Shows 94% Wear Rate, Strong Glucose Control

Senseonics reports real-world data from 5,059 Eversense 365 CGM users showing 93.8% wear time and strong glucose control metrics over one year.
SENSmedical devicediabetes management